Upsher-Smith, a Midwest-based pharmaceutical company focused on specialty brands and generics, announced the opening of its new, 270,000 square-foot manufacturing facility in Maple Grove, Minnesota. The facility offers up-to-date packaging and serialization capabilities and supports contract manufacturing for third parties.
Upsher-Smith's offerings include environmentally sustainable solvent and aqueous-based oral solid dosage (OSD) manufacturing in tablet or capsule form, powders, liquids, and suspensions. Serialized packaging solutions include OSD/liquid bottles, unit dose blisters and liquid cups, and powder filling in sachets, bottles, and cans. Outbound packaging configurations are also aggregated in accordance with the pending Drug Supply Chain Security Act (DSCSA) conformance standards.